Ignite Creation Date:
2024-05-06 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 2:22 PM
Study NCT ID:
NCT05197543
Status:
UNKNOWN
Last Update Posted:
2022-01-25
First Post:
2022-01-15
Brief Title:
AAA Rupture Risk Assessment in COVID-19 Pandemic
Sponsor:
Masaryk University
Organization:
Masaryk University
Study Overview
Official Title:
Biomechanical Rupture Risk Assessment in Management of Patients With Abdominal Aortic Aneurysm in COVID-19 Pandemic
Status:
UNKNOWN
Status Verified Date:
2022-01
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The acute phase of the COVID-19 pandemic requires a redefinition of healthcare system to increase the number of available intensive care units for COVID-19 patients This leads to the postponing of elective surgeries including the treatment of abdominal aortic aneurysm AAA The probabilistic rupture risk index PRRI recently showed its advantage over the diameter criterion in AAA rupture risk assessment Its major improvement is in increased specificity and yet has the same sensitivity as the maximal diameter criterion The objective of this study was to test the clinical applicability of the PRRI diagnostic method in a quasi-prospective observational patient cohort study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None